author-photo

Shifra Fain Shmueli

4

Papers

25

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma.

2021
Show All
- Source
- Cite
- Save
Citations (0)
NIMG-17. VALIDATION OF DIFFUSION MRI AS AN IMAGING BIOMARKER FOR BEVACIZUMAB THERAPY IN RECURRENT GLIOBLASTOMA IN A RANDOMIZED PHASE III TRIAL OF BEVACIZUMAB WITH OR WITHOUT VB-111 (GLOBE)

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

2019 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (25)